Franz Obermayr

Chief Executive Officer en Panoptes Pharma GmbH .

55 años

Health Technology

Retail Trade

Perfil

Franz Obermayr is the founder and Chief Executive Officer of Panoptes Pharma GmbH since 2013.
He was also the Head of Clinical Development at Nabriva Therapeutics Plc from 2009 to 2013.
In addition, he served as Director of Drug Discovery at GPC Biotech, Inc. Dr. Obermayr was also the Executive Vice President of Clinical Development at Kiora Pharmaceuticals, Inc. in 2021.

Cargos activos de Franz Obermayr

Empresas	Cargo	Inicio
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Chief Executive Officer	01/07/2013

Todos los cargos activos de Franz Obermayr

Antiguos cargos conocidos de Franz Obermayr.

Empresas	Cargo	Fin
KIORA PHARMACEUTICALS, INC.	Chief Executive Officer	26/07/2021
NABRIVA THERAPEUTICS PLC	Corporate Officer/Principal	01/01/2013
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Franz Obermayr.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Franz Obermayr.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
KIORA PHARMACEUTICALS, INC.	Health Technology
NABRIVA THERAPEUTICS PLC	Health Technology

Empresas privadas	2
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Retail Trade
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Health Technology